Overview

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

Status:
Terminated
Trial end date:
2019-05-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety, tolerability and antibody response of Lu AF20513 in patients with Alzheimer's disease who have completed the 16026A study.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lundbeck A/S